Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physiciansâ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
äŒæ¥ã³ãŒãBMRA
äŒç€ŸåBiomerica Inc
äžå Žæ¥Mar 17, 1980
æé«çµå¶è²¬ä»»è
ãCEOãIrani (Zackary S)
åŸæ¥å¡æ°53
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Mar 17
æ¬ç€Ÿæåšå°17571 Von Karman Avenue
éœåžIRVINE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·92614
é»è©±çªå·19493792875
ãŠã§ããµã€ãhttps://biomerica.com/
äŒæ¥ã³ãŒãBMRA
äžå Žæ¥Mar 17, 1980
æé«çµå¶è²¬ä»»è
ãCEOãIrani (Zackary S)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã